(Q38006636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Hodgkin lymphoma in patients with HIV infection: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Nihal Martis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

Current hematologic malignancy reports

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

228-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22547166%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Trends in cancer risk among people with AIDS in the United States 1980-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Hodgkin's disease in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Epstein-Barr virus-associated lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

A mouse model of allogeneic corneal endothelial cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Hodgkin lymphoma in the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Hodgkin lymphoma among patients infected with HIV in post-HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Interactions between antiretrovirals and antineoplastic drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Limitations of PET for imaging lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

Degree of immune suppression and risk of HIV-related Hodgkin lymphoma: time points matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0125-2

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

21 January 2018

1 reference

12 December 2020

Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group

1 reference

12 December 2020

Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy

1 reference

12 December 2020

High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease

1 reference

12 December 2020

Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells

1 reference

12 December 2020

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

1 reference

12 December 2020